Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement Re Updated GREET Model to Measure…
The following statement may be attributed to Beth Ellikidis, BIO's Vice President for Agriculture & Environment: “Today’s release of an updated methodology to qualify crop-based sustainable aviation fuel (SAF) for federal tax credits is a…
Learn more
Admiral William McRaven to Keynote 2024 BIO…
Retired U.S. Navy (SEAL) Four-Star Admiral and the Former Chancellor of The University of Texas System, William McRaven, to Discuss Leadership, Global Events, and the National Security Importance of Biotechnology with BIO CEO, John Crowley …
Learn more
BIO Reiterates Lack of Basis for Mexico’s Ban on…
Seed technology companies comply with Mexico’s biosafety regulations, and Mexico should do the same, BIO said today in its response to the panel set up to determine if Mexico’s ban on imports of genetically modified corn violate its commitments…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
New Executive Order Critical to Protecting Patients and Public Health
September 20, 2019
President Trump has signed an executive order focused on spurring the development of new vaccine technologies, prioritizing the production of influenza vaccines and identifying strategies for communicating the importance of influenza vaccination…
Speaker Pelosi’s Drug Pricing Plan “Crushes the Desperate Hopes of Patients and their Families”
September 19, 2019
Washington, D.C. (September 19, 2019) – Former Congressman Jim Greenwood, the President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after Speaker Nancy Pelosi and Democratic leaders in the House of…
BIO Asia-Taiwan 2019 Showcased Biotech as the Region’s Next Growth Engine
August 29, 2019
Event Brought Together Biopharma Executives and Investors from Around the World for Deal Making and Partnering Opportunities
Administration Undermines Farmers and Rural Economies With Unjustifiable Renewable Fuel Standard Waivers
August 11, 2019
Washington, D.C. (August 10, 2019) –The Biotechnology Innovation Organization (BIO) released the following statement on the administration’s decision to issue 31 small refinery exemptions under the Renewable Fuel Standard. “The administration…
BIO Proposes Greater Public Access to Information on New Agricultural Biotechnology Products
August 5, 2019
The Biotechnology Innovation Organization (BIO) today put forward a consumer-friendly proposal that would improve public access to information about new agricultural biotechnology products. Combined with a new science-based regulatory approach, BIO…
HHS Drug Importation Plan a "Misguided Attempt to Keep an Ill-Informed Campaign Promise"
July 31, 2019
Following the introduction of the Trump administration’s drug importation proposal, BIO’s President and CEO Jim Greenwood issued the following statement: “There is simply no way to adopt an importation scheme that doesn’t jeopardize the health and…
Increased Investment in Research for Debilitating Diseases is Focus of Newly Introduced Bill in Congress Today
July 23, 2019
Washington, DC (July 23, 2019) – Today, legislation that would significantly improve the ability of emerging biotechnology companies to focus their investor capital on science and biomedical innovation was introduced in the House of…
Senate Finance Drug Pricing Proposal Misses the Mark
July 23, 2019
Washington, DC (July 23, 2019) – Following the release of the Senate Finance Committee’s drug pricing proposal, Tom DiLenge, the Biotechnology Innovation Organization’s President of Advocacy, Law & Public Policy Division issued the…
BIO World Congress Showcases Green Solutions to Address Global Challenges
July 11, 2019
As presidential candidates trek across the Hawkeye State and campaign on addressing society’s most pressing challenges, biotech innovators wrapped up four days of showcasing the scientific solutions to climate change, hunger, pollution and energy…
White House Deals Blow to Seniors, Withdraws Plan to Lower Out-of-Pocket Drug Costs
July 11, 2019
BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers' rebates be passed along to…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today